
Uncertainty in an era of transformative therapy for hemophilia | Virtual Summit 2020
In this session from the WFH 2020 World Summit, Glenn Pierce will examine the evolution of gene therapy while addressing
Year: 2016
Language: English
This resource is also available in: Arabic French Russian Spanish Simplified Chinese
Author(s): World Federation of Hemophilia
Format: Document
This illustrated schematic demonstrates the normal process of blood clotting, how it is diminished when a clotting factor is lacking, and how infusion of replacement therapy works to achieve normal levels of blood clotting. It also illustrates the clotting factor cascade and highlights the points in the cascade where each type of hemophilia treatment product acts to impact the ability to form blood clots.

In this session from the WFH 2020 World Summit, Glenn Pierce will examine the evolution of gene therapy while addressing

Despite significant paradigm shifts in the medical management of hemophilia A with inhibitors and the expanding use of novel non-factor

This module was presented by Susan Cutter at the Virtual Workshop for Psychosocial Professionals in Central and South America on

In this session from the WFH 2020 Virtual Summit, Steve Kitchen, Emmanuel Favaloro, Robert Gosselin and Geoffrey Kershaw discuss: How

In this session from the WFH 2020 Virtual Summit, Steve Kitchen, Stefen Tiefenbacher, Anna Lowe and Annette Bowyer discuss: Gene

A summary of discussions held at the Eleventh WFH Global Forum on Research and Treatment Products for Bleeding Disorders which